Dr. Julie Brahmer
@JulieBrahmer
Director of @HopkinsThoracic, Director of the Upper Aerodigestive Disease Program, @bloombergkimmel, Professor of Oncology @HopkinsMedicine and @hopkinskimmel
ID:1358983980935168001
https://www.hopkinsmedicine.org/kimmel_cancer_center/cancers_we_treat/lung_cancer_program/ 09-02-2021 03:41:35
181 Tweets
1,4K Followers
115 Following
Follow People
Stephen V Liu, MD
Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Host @IASLC Podcast; Chair #TexasLung24 #PLCCLive24 #DCLung24 #HereWeGo
Jarushka Naidoo
Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University
Patrick Forde
Lung cancer & Mesothelioma @HopkinsThoracic @HopkinsKimmel Immunotherapy believer. 🇮🇪 🇺🇸
Balazs Halmos
Thoracic/precision oncology 🇭🇺🇺🇸
Narjust Florez, MD, FASCO
Assc. Director CCEP & Thoracic Oncologist @DanaFarberNews & @Harvardmed| Lung Ca in Women | Editor @Jamaonc | Co-founder @LatinasInMed | @Florez_Lab | Free
Congrats to my friend Dr Wakelee, who is an inspiration to all of us. Thank you Heather! ECOG-ACRIN Cancer Research Group Heather Wakelee
Find yourself a mentor who dances with you and don’t let go. #SheforShe #WomeninThoracicOncology #lcsm #TexasLung24 Susan Combs Scott, MD Dr. Julie Brahmer Sidney Kimmel Cancer Center – Jefferson Health Hematology & Oncology Women Physicians Group—HOWPG #mentoringmatters
Dr. Joshua Reuss doing a masterful job reviewing range of successes & failures of antibody-drug conjugates in lung cancer. It was at the Texas Lung Cancer meeting last year when I realized how great a communicator he is. He's again a remarkably compelling speaker. #TexasLung24
#TexasLung24 Vincent Lam Sidney Kimmel Cancer Center – Jefferson Health gives the best talk on Best Practices in #ALK + #lungcancer
➡️lorlatinib currently the most potent TKI ( but requires toxicity mgmt)
⬆️CNS activity ⬆️survival
➡️other treatment options- vaccines, local vs chemo consolidation
#lcsm
Gratified to see our work on #ctDNA molecular response during #immunotherapy featured in Society for Immunotherapy of Cancer #AACR24 highlights! AACR Johns Hopkins Thoracic Oncology Johns Hopkins Medicine Lavanya Sivapalan sitcancer.org/blogs/thomas-m…
Out in Nature Medicine our phase Ib study of neoadjuvant nivo/nivo+LAG-3 + chemoRT in esoph/GEJ cancer; linking ctDNA w path/immune responses and RFS. nature.com/articles/s4159… Elsa Anagnostou Johns Hopkins Thoracic Oncology Conquer Cancer, the ASCO Foundation #esophagealcancer 1/5
Here's our latest from Johns Hopkins Thoracic Oncology & Molecular OncologyLab, hot-off-the-press in Nature Medicine. What do we learn from neoadjuvant anti-PD1 & anti-LAG3 through the lens of liquid biopsies? Enjoy the read!
nature.com/articles/s4159…
Vincent Lam Cancer Research Institute Blair Landon
New Professor at Johns Hopkins Thoracic Oncology, and just in time for St. Patrick’s Day. Congratulations Patrick Forde! 🇮🇪🇮🇪🇮🇪
In 2012, Dr. Dr. Julie Brahmer presented data from the phase I study of nivolumab showing durable responses to immunotherapy in lung cancer. Hear the story behind the trial in tomorrow's special episode of Lung Cancer Considered, the IASLC podcast, with me and Dr. Narjust Florez, MD, FASCO!
Today we report in Cancer Research Communications the impact of ALK variants and co-mutations on acquired resistance patterns and survival in a clinical cohort of 309 pts mostly tx’ed with 1L alec/brig and a liquid biopsy cohort of 1118 ALK+ NSCLC pts. bit.ly/42SaYwE ALK Positive #LCSM 🧵
Don't miss the next episode of the IASLC podcast, Lung Cancer Considered, where Dr. Narjust Florez, MD, FASCO and I discuss the phase I study of nivolumab with Dr. Dr. Julie Brahmer - and close by discussing mentorship with surprise guests Drs. Elsa Anagnostou Jarushka Naidoo Patrick Forde!
Celebrating Dr Forde’s promotion to professor! I’m so proud of his amazing work and grateful for an amazing colleague and friend. Johns Hopkins Thoracic Oncology dream team!
Hot off the press in iScience journal, epigenetic therapy induces viral mimicry response together with CD8 T cell infiltration in #lungcancer . Great team work led by Michael Topper & Steve Baylin with AH Johns Hopkins Thoracic Oncology Kristen A. Marrone, MD Dr. Julie Brahmer
cell.com/iscience/fullt…
New review Lung Cancer Journal from Dr. Patrick Forde and team on neoadjuvant immunotherapy for resectable NSCLC, outlining rationale, current options, and future directions.
lungcancerjournal.info/article/S0169-…
Amazing #DAVAHawaiiLung session focused on nuanced approaches for #Immunotherapy : patient, genomic, immunologic & ctDNA features & #AI integration.Suresh S. Ramalingam, MD, FASCO Dr. Julie Brahmer Biagio Ricciuti, MD PhD Puneeth Iyengar Natalie Vokes Deepa Rangachari Jyoti Malhotra Dan Raz & ... that sunset
